Online tool to guide decisions for BRCA1/2 mutation carriers. - Wikidata - wikimedia - TriplyDB

Online tool to guide decisions for BRCA1/2 mutation carriers.

Online tool to guide decisions for BRCA1/2 mutation carriers.

http://www.wikidata.org/entity/Q35808372

about

Contralateral prophylactic mastectomy: current perspectives Feasibility evaluation of an online tool to guide decisions for BRCA1/2 mutation carriers.Genetic risk assessments in individuals at high risk for inherited breast cancer in the breast oncology care setting.Seeking balance: decision support needs of women without cancer and a deleterious BRCA1 or BRCA2 mutation A simulation model to predict the impact of prophylactic surgery and screening on the life expectancy of BRCA1 and BRCA2 mutation carriers.Substantial breast cancer risk reduction and potential survival benefit after bilateral mastectomy when compared with surveillance in healthy BRCA1 and BRCA2 mutation carriers: a prospective analysis.The effectiveness of a graphical presentation in addition to a frequency format in the context of familial breast cancer risk communication: a multicenter controlled trial.Effects of screening and systemic adjuvant therapy on ER-specific US breast cancer mortality.How can we best respect patient autonomy in breast cancer treatment decisions?Does a decision aid improve informed choice in mammography screening? Study protocol for a randomized controlled trial.A Database of Gene Expression Profiles of Korean Cancer Genome.iPrevent®: a tailored, web-based, decision support tool for breast cancer risk assessment and management.Establishing a program for individuals at high risk for breast cancer.Reduced life expectancy seen in hereditary diseases which predispose to early-onset tumors.Quantifying the natural history of breast cancer Contralateral prophylactic mastectomy in women with breast cancer: trends, predictors, and areas for future research.Development of a personalized decision aid for breast cancer risk reduction and management.Decision making for breast cancer prevention among women at elevated risk Use of the BOADICEA Web Application in clinical practice: appraisals by clinicians from various countries.Addressing inherited predisposition for breast cancer in transplant recipients.Society of Surgical Oncology Breast Disease Working Group Statement on Prophylactic (Risk-Reducing) Mastectomy.Breast cancer risk after salpingo-oophorectomy in healthy BRCA1/2 mutation carriers: revisiting the evidence for risk reduction.Risk-reducing surgery in BRCA 1/2 mutation carries: a point of view.MRI breast screening in high-risk women: cancer detection and survival analysis.Risk-reducing surgery increases survival in BRCA1/2 mutation carriers unaffected at time of family referral.Improving mutation notification when new genetic information is identified in research: a trial of two strategies in familial breast cancer.Cost Effectiveness of Gene Expression Profile Testing in Community Practice.Risk assessment: Physicians discuss motivations for rising rates of prophylactic mastectomies.

P2860

Q26744320-9EC72666-8F0E-4CAF-838E-F3509ADB10B6 Q27316521-B3501B5D-7A08-415C-BAE2-0025B1B8B3A0 Q33564013-32340ABF-6139-4A8C-9B8D-115034EA2556 Q34069150-8C3798EF-321D-4B43-9F99-EEED0951BB5A Q34097351-003C8445-3187-4191-9DB7-8985B79D289F Q34663394-DCBBA606-2B66-4FD2-82F5-35EF26B5E608 Q34693902-9E1B54D9-80A1-4539-806D-B5CD0F760993 Q34736052-8552AB65-CD76-4783-A3AE-5006A259B5BE Q35127923-8D518965-4360-4699-B463-F29CDD3BCE19 Q35704341-220C0EC8-88CA-4E21-9B97-56ED928B2EBA Q36216115-B3D97F56-17DE-47F3-9F2E-FE174B3C9444 Q36678510-D49E4F1D-CFBA-4940-ADA1-F6BCFF37CFE0 Q36983389-779000D5-698C-44E0-8DCE-B9CCECC562E6 Q37074281-765B1A06-A6FA-4049-830B-E6BFBF7F8AFA Q37235493-7735F9C2-E047-436F-BF66-76183500A636 Q37387444-C692625E-BD2C-4107-B4BE-1A153C921A19 Q37506839-F9E6472D-FF4B-4C08-907B-FB7094BA5A15 Q37720955-5E2979C6-50F9-4F9D-9B73-CB4DCF5FA357 Q38721663-9FC2FFC7-6BE2-40D6-9255-99DA8C364A52 Q38727798-6C9E2DB6-C0C6-4BDB-AA0D-77E30C3D1A26 Q39033804-86400549-A791-4D24-8E98-63EC5F6D774F Q41195564-D76CAC72-3706-455B-A4D8-E79DA99C115A Q42552179-29C77A82-D918-4018-9BC5-9CB1439A7E4B Q45243016-BF397F10-CC65-4B38-ABE4-629F474AEBB5 Q45750405-5918FE06-8C51-4803-8B09-D44CDF809B13 Q46957087-60BD4E5A-FE31-4696-B2CA-140E1A96E3A8 Q47198620-4F3AB8B7-C7D8-44E5-A431-96CED9E6D381 Q47650220-DFCA90EC-5D6D-443F-ACC8-17F9E7212CA6

P2860

Online tool to guide decisions for BRCA1/2 mutation carriers.

http://www.wikidata.org/entity/Q35808372

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Online tool to guide decisions for BRCA1/2 mutation carriers.

@ast

Online tool to guide decisions for BRCA1/2 mutation carriers.

@en

type

label

Online tool to guide decisions for BRCA1/2 mutation carriers.

@ast

Online tool to guide decisions for BRCA1/2 mutation carriers.

@en

prefLabel

Online tool to guide decisions for BRCA1/2 mutation carriers.

@ast

Online tool to guide decisions for BRCA1/2 mutation carriers.

@en

P1433

Q35808372-DE27013E-35BA-4831-8190-34F58DE3F3F8

P1476

Q35808372-05C75200-9E42-49CF-80D6-4FEA832B7B5E

P2093

Q35808372-297C8FF1-6B3F-425D-A6F5-0F92699C1F2E

Q35808372-2D513336-1773-4048-9B98-337CDA13934C

Q35808372-54369860-D957-4AAE-BDCA-E58988171148

Q35808372-5F9C3624-8E95-4CB6-A7DB-C78651184CC8

Q35808372-62BE6D80-77AC-48A3-B284-86799E37D001

Q35808372-99F261AD-9853-4FBF-845C-51B59DCD1A9B

Q35808372-A16ED2DE-FA9B-4F9E-B0D6-9756D3D36A89

Q35808372-B20DAF7A-9CA2-4D35-BC5F-2EB26A326E77

P2860

Q35808372-03F36272-D01A-466B-8172-A1E840552C12

Q35808372-0C89D300-A1F2-4287-AFBC-FD7CD918FA40

Q35808372-0D7AF17E-2AA1-4254-8AFF-ECEB155B39EC

Q35808372-0FD65260-9E75-46D2-A973-4245C15EEF5F

Q35808372-17F37E12-87C2-47E6-8037-B5B3E5F45240

Q35808372-19D5FA2F-F916-4ACC-9B53-8336DBD3CCEA

Q35808372-1B2A34D7-E05B-4D08-8806-040E0EA130D8

Q35808372-1B5263CB-013C-4A05-81E2-7E1354DD5D64

Q35808372-1DE35CEF-3122-49B0-8046-A9CB312FDFE7

Q35808372-1FEB06E4-7A71-4392-BCD4-A13D574A3D7E

P304

Q35808372-9FBB7EA0-D92D-48F0-95BA-9D687308A424

P31

Q35808372-E8060F7A-BB27-4EE0-B9ED-F9E4A3A0549A

P356

Q35808372-3B8AB24A-C3DE-42E1-89C7-CD54C93D2747

P407

Q35808372-739D2DED-DB3D-40F9-BF70-9616D7CE161C

P433

Q35808372-5733B50B-D922-48ED-A3BE-84BE79688390

P478

Q35808372-D25651A3-AACF-4B49-82AD-5F2CCA16C744

P577

Q35808372-499844DF-D80E-4B30-AC26-34C23A3B9E4C

P698

Q35808372-AF0CA14B-CCF5-48FE-811A-53B2585A4BA4

P932

Q35808372-FA4FE010-A96D-4075-97B9-1F1F3C59EFA8

P356

JCO.2011.38.6060

P1433

Journal of Clinical Oncology

P1476

Online tool to guide decisions for BRCA1/2 mutation carriers.

@en

P2093

Allison W Kurian

http://www.w3.org/2001/XMLSchema#string

Diego F Munoz

http://www.w3.org/2001/XMLSchema#string

Elizabeth A Schackmann

http://www.w3.org/2001/XMLSchema#string

Lauren Clarke

http://www.w3.org/2001/XMLSchema#string

Meredith A Mills

http://www.w3.org/2001/XMLSchema#string

Michael Smith

http://www.w3.org/2001/XMLSchema#string

Peter Rust

http://www.w3.org/2001/XMLSchema#string

Sylvia K Plevritis

http://www.w3.org/2001/XMLSchema#string

P2860

Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies

Variation of breast cancer risk among BRCA1/2 carriers.

Survival analysis of cancer risk reduction strategies for BRCA1/2 mutation carriers

Meta-analysis of BRCA1 and BRCA2 penetrance

A combined analysis of outcome following breast cancer: differences in survival based on BRCA1/BRCA2 mutation status and administration of adjuvant treatment

Inhibition of poly(ADP-ribose) polymerase in tumors from BRCA mutation carriers.

Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial

Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2

American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography

Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials

P304

497-506

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1200/JCO.2011.38.6060

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

30

http://www.w3.org/2001/XMLSchema#string

P577

2012-01-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22231042

http://www.w3.org/2001/XMLSchema#string

P932

3295552

http://www.w3.org/2001/XMLSchema#string